Ignite Creation Date:
2024-05-05 @ 10:52 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01207648
Status:
COMPLETED
Last Update Posted:
2015-05-15
First Post:
2010-09-21
Brief Title:
Retrospective Cohort Study of Rebif Use in Pediatric Multiple Sclerosis MS Subjects REPLAY
Sponsor:
EMD Serono
Organization:
EMD Serono
Study Overview
Official Title:
Retrospective Cohort Study of Rebif Use in Pediatric MS Patients
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REPLAY
Brief Summary:
The aim of this retrospective study is to review and describe safety tolerability and efficacy of Rebif subcutaneous interferon IFN-beta-1a in children and adolescents using information already recorded in medical records The study duration is 13 July 2010 first data collected to 13 July 2011 last data collected In this study Data of the subjects evaluated between 1997 and 2009 was observed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None